UroGen Pharma Ltd
URGN
Market Cap$621.99M
Close$
$15.60
13.9% upside
Current Fair Value
13.9% upsideUndervalued by 13.9% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $621.99 Million |
|---|---|
| Enterprise Value | $642.91 Million |
| Dividend Yield | $0 (0%) |
| Earnings per Share | $-2.96 |
| Beta | 0.4 |
| Outstanding Shares | 47,422,119 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -4.62 |
|---|---|
| PEG | -12.91 |
| Price to Sales | 13.7 |
| Price to Book Ratio | -13.7 |
| Enterprise Value to Revenue | 7 |
| Enterprise Value to EBIT | -6.1 |
| Enterprise Value to Net Income | -5 |
| Total Debt to Enterprise | 0.19 |
| Debt to Equity | -2.69 |
Revenue Sources
No data
Insider Trades
ESG Score
No data
About UroGen Pharma Ltd
CEO: Elizabeth Barrett